返回
李健 (Li J)
Chinese Academy of Medical Science and Peking Union Medical College
51H指数
1.9K论文数
1.4W被引数
收录论文 282
发表时间
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trialsGlecirasib联合或不联合西妥昔单抗治疗既往经治的局部晚期或转移性KRASG12C突变结直肠癌(JAB-21822-1002和JAB-21822-1007):两项开放标签、非随机化I/II期临床试验

